Innate Pharma (IPHA) Institutional Ownership $1.88 -0.02 (-1.06%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Innate Pharma (NASDAQ:IPHA)CurrentInstitutional OwnershipPercentage0.16%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$307.60KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$489.39K Get IPHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Innate Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPHA Institutional Buying and Selling by Quarter Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Innate Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/10/2024 Exchange Traded Concepts LLC77,350$177K0.0%-10.3%0.096% 2/13/2024Optiver Holding B.V.22,705$64K0.0%-88.1%0.028% 1/5/2024 Exchange Traded Concepts LLC46,888$131K0.0%+34.0%0.058% 11/13/2023Optiver Holding B.V.190,219$481K0.0%+132.6%0.236% 10/18/2023 Exchange Traded Concepts LLC34,998$89K0.0%-17.5%0.043% 8/10/2023Optiver Holding B.V.81,796$257K0.0%-63.5%0.102% 7/20/2023 Exchange Traded Concepts LLC42,431$133K0.0%N/A0.053% 5/11/2023Optiver Holding B.V.224,097$636K0.0%+112.3%0.279% 2/14/2023Susquehanna International Group LLP13,315$50K0.0%N/A0.017% 2/10/2023Optiver Holding B.V.105,534$394K0.0%-43.1%0.132% 8/10/2022Optiver Holding B.V.181,944$491K0.0%+366.8%0.228% 2/9/2022Alps Advisors Inc.93,718$429K0.0%N/A0.118% 12/1/2021Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/16/2021Two Sigma Securities LLC17,119$106K0.0%N/A0.022% 11/15/2021Pura Vida Investments LLC82,509$509K0.0%N/A0.104% 11/15/2021Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/12/2021Affinity Asset Advisors LLC125,000$771K0.2%N/A0.158% 5/21/2021Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/20/2021Optiver Holding B.V.30,284$131K0.0%N/A0.038% 5/18/2021Millennium Management LLC49,734$214K0.0%-9.1%0.063% 5/18/2021Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/14/2021Optiver Holding B.V.55,588$240K0.0%N/A0.070% (Data available from 1/1/2016 forward) IPHA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPHA shares? During the previous two years, the following institutional investors and hedge funds held shares of Innate Pharma shares: Exchange Traded Concepts LLC ($177K), and Optiver Holding B.V. ($64K), Susquehanna International Group LLP ($50K).Learn more on IPHA's institutional investors. What percentage of Innate Pharma stock is owned by institutional investors? 0.16% of Innate Pharma stock is owned by institutional investors. Learn more on IPHA's institutional investor holdings. Which institutional investors have been buying Innate Pharma stock? The following institutional investors have purchased Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($226.99K), Exchange Traded Concepts LLC ($54.32K), and Susquehanna International Group LLP ($13.32K). How much institutional buying is happening at Innate Pharma? Institutional investors have bought a total of 294,622 shares in the last 24 months. This purchase volume represents approximately $825.65K in transactions. Which Innate Pharma major shareholders have been selling company stock? The following institutional investors have sold Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($389.59K), and Exchange Traded Concepts LLC ($16.32K). How much institutional selling is happening at Innate Pharma? Institutional investors have sold a total of 405,911 shares in the last 24 months. This volume of shares sold represents approximately $1.24M in transactions. Related Companies SLN Major Shareholders AURA Major Shareholders ALT Major Shareholders AQST Major Shareholders ARCT Major Shareholders SAGE Major Shareholders SIGA Major Shareholders VERV Major Shareholders KALV Major Shareholders PRTC Major Shareholders This page (NASDAQ:IPHA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
